Abstract:TIGIT expression on natural killer (NK) cells is associated with dysfunction during chronic HIV infection, but the phenotype and biological functions of these cells in the context of acute HIV-1 infection remain poorly understood. Here, 19 acutely infected HIV-1 patients traced at first, third and twelfth month, and age-matched patients with chronic HIV-1 infection were enrolled to investigate the phenotype and functions of TIGIT expression on NK cells. We found that TIGIT-expressing NK cells did not increase in frequency in the first, third and twelfth month of infection until chronic HIV-1 infection lasted over 2 years. The number of TIGIT + NK cells in acute infection was positively associated with HIV-1 viral load ( r = 0.53, P = 0.0009). CD96 was significantly upregulated on NK cells after acute infection for 1 month and in chronic infection over 2 years, while CD226 was downregulated in chronic infection over 2 years. Further, at different stages of infection, CD96 − CD226 + cells diminished among total NK cells, TIGIT + NK and TIGIT − NK cells, while CD96 + CD226 − cells expanded. Reduced CD96 − CD226 + cells and elevated CD96 + CD226 − cells among NK cells especially TIGIT − NK cells, had opposite associations with viral load in the first month of infection, as well as CD4 T-cell counts in including the twelfth month and more than 2 years of chronic infection. In both HIV-1-infected individuals and healthy donors, TIGIT was predominantly expressed in NKG2A − NKG2C + NK cells, with a significantly higher proportion than in NKG2A + NKG2C − NK cells. Moreover, the frequencies of TIGIT + NK cells were positively associated with the frequencies of NKG2A − NKG2C + NK cells in acute infection ( r = 0.62, P < 0.0001), chronic infection ( r = 0.37, P = 0.023) and healthy donors ( r = 0.36, P = 0.020). Enhanced early activation and coexpression of CD38 and HLA-DR in TIGIT + NK cells were detected compared to TIGIT − NK cells, both of which were inversely associated with the decrease in CD4 T-cell counts in both acute and chronic HIV-1 infection. The ability of TIGIT + NK cells to produce TNF-α, IFN-γ and CD107a degranulation substance were consistently weaker than that of TIGIT − NK cells in both acute and chronic infection. Moreover, the functionalities of TIGIT + NK cells were lower than those of TIGIT − NK cells, except for TNF-α − CD107a + IFN-γ − NK cells. These findings highlight the phenotype and functional characteristics of TIGIT-expressing NK cells which have poor capabilities in inhibiting HIV-1 replication and maintaining CD4 T-cell counts.

Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status.

Impaired natural killer cell-induced antibody-dependent cell-mediated cytotoxicity is associated with human immunodeficiency virus-1 disease progression.

HIV-1 Induced Changes in HLA-C∗03 : 04-Presented Peptide Repertoires Lead to Reduced Engagement of Inhibitory Natural Killer Cell Receptors

Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy

Changes in NK Cell Subsets and Receptor Expressions in HIV-1 Infected Chronic Patients and HIV Controllers

Changes in NK cell counts and receptor expressions and emergence of CD3dim/CD56+ cells in HIV-1 infected patients in China

Modulation of expression of the MHC class I-binding natural killer cell receptors, and NK activity in relation to viral load in HIV-infected/AIDS patients

Immune Dysfunctions of CD56neg NK Cells Are Associated With HIV-1 Disease Progression

Natural killer cell subsets and cell surface receptors in the early stage of HIV-1 infection in the MSM(men having sex with men) population

Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56-CD16+ Natural Killer Cell Subset Is Associated with Natural Killer Cell Dysfunction in Chronic HIV-1 Clade C Infection

Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4+ T Cells

Analysis of the Characteristics of TIGIT-Expressing CD3−CD56+NK Cells in Controlling Different Stages of HIV-1 Infection

Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells.

NKp30 and NKG2D contribute to natural killer recognition of HIV-infected cells

Natural killer cell counts in primary HIV infection predicts disease progression and immune restoration after treatment

IL-10+ NK and TGF-β+ NK cells play negative regulatory roles in HIV infection

Adaptive NK Cells Rapidly Expand during Acute HIV Infection and Persist Despite Early Initiation of Antiretroviral Therapy

Increased early activation of CD56dimCD16dim/- natural killer cells in immunological non-responders correlates with CD4+ T-cell recovery

Implications of the accumulation of CXCR5+ NK cells in lymph nodes of HIV-1 infected patients

CD56-negative NK cells: Frequency in peripheral blood, expansion during HIV-1 infection, functional capacity, and KIR expression

Function of ex vivo stimulated Natural killer T cells from patients with chronic HIV-1 infection